20082019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

  • 48 Article
  • 1 Meeting Abstract
  • 1 Comment/Letter to the editor
  • 1 Review article

Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

Peters, G. J., Giovannetti, E., Honeywell, R. J. & Ciccolini, J., 2019, In : British Journal of Clinical Pharmacology.

Research output: Contribution to journalComment/Letter to the editorAcademic

Open Access

DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors.

Honeywell, R. J., Sarkisjan, D., Kristensen, M. H., de Klerk, D. J. & Peters, G. J., 19 Jan 2019, In : Nucleosides, Nucleotides and Nucleic Acids. p. 1-13

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

RX-3117 (fluorocyclopentenyl cytosine): a novel specific antimetabolite for selective cancer treatment

Balboni, B., el Hassouni, B., Honeywell, R. J., Sarkisjan, D., Giovannetti, E., Poore, J., Heaton, C., Peterson, C., Benaim, E., Lee, Y. B., Kim, D. J. & Peters, G. J., 2019, In : Expert Opinion on Investigational Drugs. 28, 4, p. 311-322

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Cytidine deaminase enzymatic activity is a prognostic biomarker in gemcitabine/platinum-treated advanced non-small-cell lung cancer: a prospective validation study

Italian Oncological Group of Clinical Research (GOIRC), Tibaldi, C., Camerini, A., Tiseo, M., Mazzoni, F., Barbieri, F., Vittimberga, I., Brighenti, M., Boni, L., Baldini, E., Gilli, A., Honeywell, R., Chartoire, M., Peters, G. J. & Giovannetti, E., 27 Nov 2018, In : British Journal of Cancer. 119, 11, p. 1326-1331 6 p.

Research output: Contribution to journalArticleAcademicpeer-review